Sun Pharma, Ferring Pharma sign agreement to launch CARITEC in India

CARITEC is indicated for the prevention of excessive bleeding in women after vaginal or caesarean child birth.

78
Deal
Picture: Pixabay

Sun Pharmaceutical Industries announced that one of its wholly owned subsidiaries has entered into a license agreement with Ferring Pharmaceuticals, a subsidiary of Switzerland-based biopharmaceuticals MNC Ferring Pharmaceuticals, to commercialise a Room Temperature Stable (RTS) formulation of obstetric drug, CARITEC (Carbetocin RTS) in India.

CARITEC is indicated for the prevention of excessive bleeding in women after vaginal or caesarean child birth. The condition is commonly known as post-partum hemorrhage (PPH).

As per agreement terms, Sun Pharma is granted rights for co-marketing of the drug in India in the private market under the brand name CARITEC. Ferring has developed the drug and received approval from the Drugs Controller General of India (DCGI) for introducing the drug in India.

Stethoscope Doctor Medical Devices Doctor
Picture: Pixabay

Kirti Ganorkar, CEO-India business, Sun Pharma, said, “PPH is one of the leading causes of maternal mortality worldwide. As per WHO, 25 per cent of maternal deaths occur due to this condition.

Through our collaboration with Ferring, we are introducing an innovative medicine that will help in reducing thousands of deaths from PPH every year. We believe this unique RTS formulation of Carbetocin will play an important role in PPH prevention in India.”

PPH is a frequent complication of child birth and its reported incidence in India is two to four per cent after vaginal delivery and six per cent after caesarean section. As per a survey conducted in India, PPH contributes to 38 per cent of maternal deaths.

Glenmark launches drug for the treatment of seizures

Celon launches an emulsion-based drug to treat Black Fungus

JB Chemicals launches medicated Nicotine lozenges: Quit smoking

Merck launches synthetic cholesterol product

BDR Pharma launches generic Rucaparib

Bal Pharma launches Favipiravir tablets in India

Revolution in Diagnostics industry with new age technology

Bird Flu: China reports first human case of H10N3

Lilly India gets nod for restricted EU of monoclonal antibody drugs

Glenmark launches drug for the treatment of seizures

Celon launches an emulsion-based drug to treat Black Fungus

Modern Lab to produce Amphotericin B Inj to treat black fungus

Subscribe for daily free updates on Telegram

Follow us on Facebook and Linkedin

For daily free updates on WhatsApp, click here

Enter your email address:

Delivered by FeedBurner